376 related articles for article (PubMed ID: 21316446)
1. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
Viridén A; Abrahmsén-Alami S; Wittgren B; Larsson A
Eur J Pharm Biopharm; 2011 Aug; 78(3):470-9. PubMed ID: 21316446
[TBL] [Abstract][Full Text] [Related]
2. Model drug release from matrix tablets composed of HPMC with different substituent heterogeneity.
Viridén A; Larsson A; Schagerlöf H; Wittgren B
Int J Pharm; 2010 Nov; 401(1-2):60-7. PubMed ID: 20883761
[TBL] [Abstract][Full Text] [Related]
3. Effect of source variation on drug release from HPMC tablets: linear regression modeling for prediction of drug release.
Piriyaprasarth S; Sriamornsak P
Int J Pharm; 2011 Jun; 411(1-2):36-42. PubMed ID: 21420475
[TBL] [Abstract][Full Text] [Related]
4. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
Rujivipat S; Bodmeier R
Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
[TBL] [Abstract][Full Text] [Related]
5. Study of the critical points and the role of the pores and viscosity in carbamazepine hydrophilic matrix tablets.
Aguilar-de-Leyva A; Cifuentes C; Rajabi-Siahboomi AR; Caraballo I
Eur J Pharm Biopharm; 2012 Jan; 80(1):136-42. PubMed ID: 21946473
[TBL] [Abstract][Full Text] [Related]
6. The effect of substitution pattern of HPMC on polymer release from matrix tablets.
Viridén A; Larsson A; Wittgren B
Int J Pharm; 2010 Apr; 389(1-2):147-56. PubMed ID: 20100556
[TBL] [Abstract][Full Text] [Related]
7. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets.
Viridén A; Wittgren B; Larsson A
Eur J Pharm Sci; 2009 Feb; 36(2-3):297-309. PubMed ID: 19038336
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
Tajarobi F; Abrahmsén-Alami S; Carlsson AS; Larsson A
Eur J Pharm Sci; 2009 May; 37(2):89-97. PubMed ID: 19429415
[TBL] [Abstract][Full Text] [Related]
9. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: effect of HPMC of different viscosity grades.
Escudero JJ; Ferrero C; Jiménez-Castellanos MR
Int J Pharm; 2008 Mar; 351(1-2):61-73. PubMed ID: 17996408
[TBL] [Abstract][Full Text] [Related]
10. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
11. The influence of HPMC viscosity as FRC parameter on the release of low soluble drug from hydrophylic matrix tablets.
Novak SD; Kuhelj V; Vrečer F; Baumgartner S
Pharm Dev Technol; 2013; 18(2):343-7. PubMed ID: 21916601
[TBL] [Abstract][Full Text] [Related]
12. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets.
Ghimire M; Hodges LA; Band J; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
J Control Release; 2010 Oct; 147(1):70-5. PubMed ID: 20600400
[TBL] [Abstract][Full Text] [Related]
13. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
[TBL] [Abstract][Full Text] [Related]
14. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug.
Zeng A; Yuan B; Fu Q; Wang C; Zhao G
Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948
[TBL] [Abstract][Full Text] [Related]
15. The consequence of the chemical composition of HPMC in matrix tablets on the release behaviour of model drug substances having different solubility.
Viridén A; Wittgren B; Larsson A
Eur J Pharm Biopharm; 2011 Jan; 77(1):99-110. PubMed ID: 21081160
[TBL] [Abstract][Full Text] [Related]
16. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
Li FQ; Hu JH
Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
[TBL] [Abstract][Full Text] [Related]
17. Characterization of physicochemical properties of hydroxypropyl methylcellulose (HPMC) type 2208 and their influence on prolonged drug release from matrix tablets.
Devjak Novak S; Šporar E; Baumgartner S; Vrečer F
J Pharm Biomed Anal; 2012 Jul; 66():136-43. PubMed ID: 22510313
[TBL] [Abstract][Full Text] [Related]
18. The effect of chemical heterogeneity of HPMC on polymer release from matrix tablets.
Viridén A; Wittgren B; Andersson T; Larsson A
Eur J Pharm Sci; 2009 Mar; 36(4-5):392-400. PubMed ID: 19049865
[TBL] [Abstract][Full Text] [Related]
19. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
[TBL] [Abstract][Full Text] [Related]
20. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitution.
Escudero JJ; Ferrero C; Jiménez-Castellanos MR
Int J Pharm; 2010 Mar; 387(1-2):56-64. PubMed ID: 19969052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
